- Home
- EJH vs KZIA Comparison
EJH vs KZIA Comparison
Compare EJH & KZIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EJH | KZIA |
|---|---|---|
| Founded | 2018 | 1994 |
| Country | China | Australia |
| Employees | N/A | N/A |
| Industry | Other Consumer Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 72.4M | 93.2M |
| IPO Year | 2019 | 2002 |
Fundamental Metrics
Financial Performance| Metric | EJH | KZIA |
|---|---|---|
| Price | $0.09 | $7.15 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $17.67 |
| AVG Volume (30 Days) | ★ 2.9M | 145.2K |
| Earning Date | 10-30-2025 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $0.07 | $0.64 |
| 52 Week High | $12.45 | $17.40 |
Technical Indicators
Market Signals| Indicator | EJH | KZIA |
|---|---|---|
| Relative Strength Index (RSI) | 25.82 | 44.91 |
| Support Level | $0.08 | $5.64 |
| Resistance Level | $1.04 | $7.11 |
| Average True Range (ATR) | 0.08 | 0.81 |
| MACD | -0.01 | -0.18 |
| Stochastic Oscillator | 1.92 | 8.72 |
Price Performance
Historical ComparisonAbout EJH E-Home Household Service Holdings Limited
E-Home Household Service Holdings Ltd is a household service company providing integrated household services through its website and WeChat platform across China. The company offers services including home appliance and housekeeping services. It operates its business mainly by receiving orders online and providing services offline. Its operations are organized into four reportable segments: appliance installation and maintenance services, housekeeping services, senior care services, and educational consulting services. The company generates the majority of its revenue from installation and maintenance.
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is a biotechnology company focused on pharmaceutical drug development in oncology. The company has a portfolio of development candidates across various technologies targeting multiple cancer indications. Its primary program is Paxalisib, an investigational brain-penetrant inhibitor of the PI3K/Akt/mTOR pathway, designed for the treatment of brain cancer. The company develops targeted therapies aimed at addressing medical needs in oncology. The company operates in Australia and the United States.